Health Canada Provides a No-Objection Letter to Atma Journey Centers: A Clinical Trial Assessing Psilocybin Safety and Exploring Psychological Outcome in Licensed Medical Practitioners
CALGARY, AB, Jan. 7, 2022 /CNW/ - ATMA Journey Centers Inc. (“ATMA”) has been granted a No Objection Letter (“NOL”) by Health […]
Read more